{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:22:37Z","timestamp":1795072957382,"version":"4.10.2"},"reference-count":94,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:sec>\n<jats:title>Background &amp; Objective:<\/jats:title>\n<jats:p> Neurological diseases are becoming a significant problem\nworldwide, with the elderly at a higher risk of being affected. Several researchers have investigated\nthe neuroprotective effects of Carvacrol (CAR) (5-isopropyl-2-methyl phenol). This review systematically\nsurveys the existing literature on the impact of CAR when used as a neuroprotective agent\nin neurological diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The systematic review involved English articles published in the last ten years obtained\nfrom PubMed, Google Scholar, and Scopus databases. The following descriptors were used to\nsearch the literature: \u201cCarvacrol\u201d [Title] AND \u201cneuroprotective (neuroprotection)\u201d [Title] OR\n\u201cstroke, traumatic brain injury, Alzheimer's disease, Parkinson's disease, seizure, epilepsy [Title].<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 208 articles were retrieved during the search process, but only 20 studies met\nthe eligibility criteria and were included for review. A total of 20 articles were identified, in which\nthe efficacy of CAR was described in experimental models of stroke, traumatic brain injury, Parkinson\u2019s\ndisease, Alzheimer\u2019s disease, epilepsy, and seizure, through motor deficits improvements in\nneurochemical activity, especially antioxidant systems, reducing inflammation, oxidative stress\nand apoptosis as well as inhibition of TRPC1 and TRPM7.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion :<\/jats:title>\n<jats:p>The data presented in this study support the beneficial impact of CAR on behavioural\nand neurochemical deficits. CAR benefits accrue because of its anti-apoptotic, antioxidant, and anti-\ninflammatory properties. Therefore, CAR has emerged as an alternative treatment for neurological\ndisorders based on its properties.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527320666210506185042","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T20:45:56Z","timestamp":1620679556000},"page":"942-953","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article"],"prefix":"10.2174","volume":"20","author":[{"given":"Mohammad Yassin","family":"Zamanian","sequence":"first","affiliation":[{"name":"Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kujawska","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30, Poznan, 60-631, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Nikbakhtzadeh","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Hassanshahi","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Ramezanpour","sequence":"additional","affiliation":[{"name":"Shohada Hospital, Bandar Gaz, Golestan University of Medical Sciences, Bandar Gaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Kamiab","sequence":"additional","affiliation":[{"name":"Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Bazmandegan","sequence":"additional","affiliation":[{"name":"Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2006","unstructured":"Neurological disorders: Public health challenges 2006","journal-title":"Neurological disorders: Public health challenges"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.24897","volume":"81","author":"Gooch CL","year":"2017","unstructured":"Gooch CL; Pracht E; Borenstein AR; The burden of neurological disease in the United States: A summary report and call to action. Ann Neurol 2017,81(4),479-84","journal-title":"Ann Neurol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"106890","DOI":"10.1016\/j.yebeh.2019.106890","volume":"104","author":"Smith J.A.D.","year":"2020","unstructured":"Smith J.A.D.; Kirmse R.; Van Enkevort E.; Armacost M.; Dhamija R.; Trehan A.; Liu C.; Improving neuropsychological seizure lateralization in Spanish-speaking people with epilepsy in the US: The need to account for education and demographic differences. Epilepsy Behav 2020,104(Pt A),106890","journal-title":"Epilepsy Behav"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrneurol.2015.229","volume":"12","author":"Henry J.D.","year":"2016","unstructured":"Henry J.D.; Von Hippel W.; Molenberghs P.; Lee T.; Sachdev P.S.; Clinical assessment of social cognitive function in neurological disorders. Nat Rev Neurol 2016,12(1),28-39","journal-title":"Nat Rev Neurol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1148\/radiol.2351041768","volume":"235","author":"Thrall JHJR","year":"2005","unstructured":"Thrall JHJR; Prevalence and costs of chronic disease in a health care system structured for treatment of acute illness. Radiology 2005,235(1),9-12","journal-title":"Radiology"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"7151780","DOI":"10.1155\/2019\/7151780","volume":"2019","author":"Mendon\u00e7a-Junior FJ","year":"2019","unstructured":"Mendon\u00e7a-Junior FJ; Scotti MT; Nayarisseri A; Natural bioactive products with antioxidant properties useful in neurodegenerative diseases. Oxid Med Cell Longev 2019,2019,7151780","journal-title":"Oxid Med Cell Longev"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/1389200218666170710190249","volume":"19","author":"Parvez MK","year":"2018","unstructured":"Parvez MK; Natural or plant products for the treatment of neurological disorders: Current knowledge. Curr Drug Metab 2018,19(5),424-8","journal-title":"Curr Drug Metab"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1570159X16666180911124605","volume":"17","author":"Rehman MU","year":"2019","unstructured":"Rehman MU; Wali AF; Ahmad A; Neuroprotective strategies for neurological disorders by natural products: An update. Curr Neuropharmacol 2019,17(3),247-67","journal-title":"Curr Neuropharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/jcm9020430","volume":"9","author":"Salehi B.","year":"2020","unstructured":"Salehi B.; Calina D.; Docea A.O.; Koirala N.; Aryal S.; Lombardo D.; Pasqua L.; Taheri Y.; Marina Salgado Castillo C.; Martorell M.; Martins N.; Iriti M.; Suleria H.A.R.; Sharifi-Rad J.; Curcumin\u2019s nanomedicine formulations for therapeutic application in neurological diseases. J Clin Med 2020,9(2),430","journal-title":"J Clin Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.2174\/0929867324666170724102743","volume":"24","author":"Sarubbo F.","year":"2017","unstructured":"Sarubbo F.; Moranta D.; Asensio V.J.; Miralles A.; Esteban S.; Effects of resveratrol and other polyphenols on the most common brain age-related diseases. Curr Med Chem 2017,24(38),4245-4266","journal-title":"Curr Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1515\/revneuro-2018-0080","volume":"30","author":"Amanzadeh E.","year":"2019","unstructured":"Amanzadeh E.; Esmaeili A.; Rahgozar S.; Nourbakhshnia M.; Application of quercetin in neurological disorders: From nutrition to nanomedicine. Rev Neurosci 2019,30(5),555-572","journal-title":"Rev Neurosci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"110646","DOI":"10.1016\/j.fct.2019.110646","volume":"132","author":"Ahmed S.","year":"2019","unstructured":"Ahmed S.; Khan H.; Aschner M.; Hasan M.M.; Hassan S.T.S.; Therapeutic potential of naringin in neurological disorders. Food Chem Toxicol 2019,132,110646","journal-title":"Food Chem Toxicol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuro.2018.05.005","volume":"67","author":"Noshy P.A.","year":"2018","unstructured":"Noshy P.A.; Elhady M.A.; Ameliorative effect of carvacrol against propiconazole-induced neurobehavioral toxicity in rats. Neurotoxicology 2018,67,141-149","journal-title":"Neurotoxicology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1590\/0004-282x20190079","volume":"77","author":"Hamzehloei L.","year":"2019","unstructured":"Hamzehloei L.; Rezvani M.E.; Rajaei Z.; Effects of carvacrol and physical exercise on motor and memory impairments associated with Parkinson\u2019s disease. Arq Neuropsiquiatr 2019,77(7),493-500","journal-title":"Arq Neuropsiquiatr"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"116795","DOI":"10.1016\/j.lfs.2019.116795","volume":"235","author":"Guan X.","year":"2019","unstructured":"Guan X.; Li X.; Yang X.; Yan J.; Shi P.; Ba L.; Cao Y.; Wang P.; The neuroprotective effects of carvacrol on ischemia\/reperfusion-induced hippocampal neuronal impairment by ferroptosis mitigation. Life Sci 2019,235,116795","journal-title":"Life Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1089\/neu.2012.2575","volume":"29","author":"Peters M.","year":"2012","unstructured":"Peters M.; Trembovler V.; Alexandrovich A.; Parnas M.; Birnbaumer L.; Minke B.; Shohami E.; Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice. J Neurotrauma 2012,29(18),2831-2834","journal-title":"J Neurotrauma"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuint.2019.02.021","volume":"126","author":"Tiefensee Ribeiro C.","year":"2019","unstructured":"Tiefensee Ribeiro C.; Gasparotto J.; Petiz L.L.; Brum P.O.; Peixoto D.O.; Kunzler A.; da Rosa Silva H.T.; Bortolin R.C.; Almeida R.F.; Quintans-Junior L.J.; Ara\u00fajo A.A.; Moreira J.C.F.; Gelain D.P.; Oral administration of carvacrol\/\u03b2-cyclodextrin complex protects against 6-hydroxydopamine-induced dopaminergic denervation. Neurochem Int 2019,126,27-35","journal-title":"Neurochem Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12906-018-2219-4","volume":"18","author":"Scalas D.","year":"2018","unstructured":"Scalas D.; Mandras N.; Roana J.; Tardugno R.; Cuffini A.M.; Ghisetti V.; Benvenuti S.; Tullio V.; Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible\/not-susceptible Cryptococcus neoformans strains. BMC Complement Altern Med 2018,18(1),143","journal-title":"BMC Complement Altern Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.3390\/molecules18066161","volume":"18","author":"Zotti M.","year":"2013","unstructured":"Zotti M.; Colaianna M.; Morgese M.G.; Tucci P.; Schiavone S.; Avato P.; Trabace L.; Carvacrol: From ancient flavoring to neuromodulatory agent. Molecules 2013,18(6),6161-6172","journal-title":"Molecules"},{"key":"ref=20","first-page":"144","volume":"15","author":"Shanmugam K.R.","year":"2019","unstructured":"Shanmugam K.R.; Siva M.; Ravi S.; Shanmugam B.; Reddy K.S.; Bioactive compound of Ocimum sanctum carvacrol supplementation attenuates fluoride toxicity in sodium fluoride intoxicated rats: A study with respect to clinical aspect. Pharmacogn Mag 2019,15(62),144","journal-title":"Pharmacogn Mag"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/molecules25081807","volume":"25","author":"Baranauskaite J.","year":"2020","unstructured":"Baranauskaite J.; Sadauskiene I.; Liekis A.; Kasauskas A.; Lazauskas R.; Zlabiene U.; Masteikova R.; Kopustinskiene D.M.; Bernatoniene J.; Natural compounds rosmarinic acid and carvacrol counteract aluminium-induced oxidative stress. Molecules 2020,25(8),1807","journal-title":"Molecules"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jbt.20355","volume":"29","author":"Aristatile B","year":"2015","unstructured":"Aristatile B; Al-Numair KS; Al-Assaf AH; Veeramani C; Protective effect of carvacrol on oxidative stress and cellular DNA damage induced by UVB irradiation in human peripheral lymphocytes. J Biochem Mol Toxicol 2015,29(11),497-507","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/j.1742-7843.2010.00609.x","volume":"107","author":"Guimar\u00e3es AG","year":"2010","unstructured":"Guimar\u00e3es AG; Oliveira GF; Melo MS; Cavalcanti SC; Antoniolli AR; Bonjardim LR; Bioassay\u2010guided evaluation of antioxidant and antinociceptive activities of carvacrol. Basic Clin Pharmacol Toxicol 2010,107(6),949-57","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"11034","DOI":"10.3390\/molecules200611034","volume":"20","author":"Yuan G","year":"2015","unstructured":"Yuan G; Lv H; Yang B; Chen X; Sun HJM; Physical properties, antioxidant and antimicrobial activity of chitosan films containing carvacrol and pomegranate peel extract. Molecules 2015,20(6),11034-45","journal-title":"Molecules"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10616-011-9389-y","volume":"64","author":"Yin QH","year":"2012","unstructured":"Yin QH; Yan FX; Zu XY; Wu YH; Wu XP; Liao MC; Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology 2012,64(1),43-51","journal-title":"Cytotechnology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ptr.2063","volume":"21","author":"Jukic M.","year":"2007","unstructured":"Jukic M.; Politeo O.; Maksimovic M.; Milos M.; Milos M.; \n                        In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone. Phytother Res 2007,21(3),259-261","journal-title":"Phytother Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neuroscience.2017.05.013","volume":"356","author":"Dati L.M.","year":"2017","unstructured":"Dati L.M.; Ulrich H.; Real C.C.; Feng Z.P.; Sun H.S.; Britto L.R.; Carvacrol promotes neuroprotection in the mouse hemiparkinsonian model. Neuroscience 2017,356,176-181","journal-title":"Neuroscience"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e33584","DOI":"10.1371\/journal.pone.0033584","volume":"7","author":"Yu H.","year":"2012","unstructured":"Yu H.; Zhang ZL.; Chen J.; Pei A.; Hua F.; Qian X.; He J.; Liu C.F.; Xu X.; Carvacrol, a food-additive, provides neuroprotection on focal cerebral ischemia\/reperfusion injury in mice. PLoS One 2012,7(3),e33584","journal-title":"PLoS One"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainresbull.2018.01.017","volume":"139","author":"Lins L.C.R.F.","year":"2018","unstructured":"Lins L.C.R.F.; Souza M.F.; Bispo J.M.M.; Gois A.M.; Melo T.C.S.; Andrade R.A.S.; Quintans-Junior L.J.; Ribeiro A.M.; Silva R.H.; Santos J.R.; Marchioro M.; Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine. Brain Res Bull 2018,139,9-15","journal-title":"Brain Res Bull"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4079425","DOI":"10.1155\/2017\/4079425","volume":"2017","author":"Wang P","year":"2017","unstructured":"Wang P; Luo Q; Qiao H; The neuroprotective effects of carvacrol on ethanol-induced hippocampal neurons impairment via the antioxidative and antiapoptotic pathways. Oxid Med Cell Longev 2017,2017,4079425","journal-title":"Oxid Med Cell Longev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3389\/fphar.2019.00998","volume":"10","author":"Hou N.","year":"2019","unstructured":"Hou N.; Mai Y.; Qiu X.; Yuan W.; Li Y.; Luo C.; Liu Y.; Zhang G.; Zhao G.; Luo J.D.; Carvacrol attenuates diabetic cardiomyopathy by modulating the PI3K\/AKT\/GLUT4 pathway in diabetic mice. Front Pharmacol 2019,10,998","journal-title":"Front Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12565-019-00514-1","volume":"95","author":"Chun Y.L.","year":"2020","unstructured":"Chun Y.L.; Kim M.; Kim Y.H.; Kim N.; Yang H.; Park C.; Huh Y.; Jung J.; Carvacrol effectively protects demyelination by suppressing transient receptor potential melastatin 7 (TRPM7) in Schwann cells. Anat Sci Int 2020,95(2),230-239","journal-title":"Anat Sci Int"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ceca.2008.11.009","volume":"45","author":"Parnas M.","year":"2009","unstructured":"Parnas M.; Peters M.; Dadon D.; Lev S.; Vertkin I.; Slutsky I.; Minke B.; Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. Cell Calcium 2009,45(3),300-309","journal-title":"Cell Calcium"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nn1692","volume":"9","author":"Xu H.","year":"2006","unstructured":"Xu H.; Delling M.; Jun J.C.; Clapham D.E.; Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat Neurosci 2006,9(5),628-635","journal-title":"Nat Neurosci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s10753-016-0392-5","volume":"39","author":"Li Z.","year":"2016","unstructured":"Li Z.; Hua C.; Pan X.; Fu X.; Wu W.; Carvacrol exerts neuroprotective effects via suppression of the inflammatory response in middle cerebral artery occlusion rats. Inflammation 2016,39(4),1566-1572","journal-title":"Inflammation"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13041-015-0102-5","volume":"8","author":"Chen W.","year":"2015","unstructured":"Chen W.; Xu B.; Xiao A.; Liu L.; Fang X.; Liu R.; Turlova E.; Barszczyk A.; Zhong X.; Sun C.L.; Britto L.R.; Feng Z.P.; Sun H.S.; TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury. Mol Brain 2015,8(1),11","journal-title":"Mol Brain"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"35346","DOI":"10.1074\/jbc.M507606200","volume":"280","author":"Lievremont JP","year":"2005","unstructured":"Lievremont JP; Numaga T; Vazquez G; The role of canonical transient receptor potential 7 in B-cell receptor-activated channels. J Biol Chem 2005,280(42),35346-51","journal-title":"J Biol Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/cells3020288","volume":"3","author":"Zheng F","year":"2014","unstructured":"Zheng F; Phelan KD; The role of canonical transient receptor potential channels in seizure and excitotoxicity. Cells 2014,3(2),288-303","journal-title":"Cells"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"Moher D.","year":"2015","unstructured":"Moher D.; Shamseer L.; Clarke M.; Ghersi D.; Liberati A.; Petticrew M.; Shekelle P.; Stewart L.A.; Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev PRISMA-P Group2015,4(1),1","journal-title":"Syst Rev"},{"key":"ref=40","first-page":"227","volume":"25","author":"Kelly J.","year":"2014","unstructured":"Kelly J.; Sadeghieh T.; Adeli K.; Peer review in scientific publications: Benefits, critiques,","journal-title":"EJIFCC"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","volume":"16","author":"Jayaraj RL","year":"2019","unstructured":"Jayaraj RL; Azimullah S; Beiram R; Jalal FY; Neuroinflammation: Friend and foe for ischemic stroke. J Neuroinflammation 2019,16(1),142","journal-title":"J Neuroinflammation"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.34172\/jhp.2020.16","volume":"9","author":"Bazmandegan G","year":"2020","unstructured":"Bazmandegan G; Shamsizadeh A; FathiNajafi M; Iranian brown propolis possesses neuroprotective effect against ischemic neuronal damage in mice. J Herbmed Pharmacol 2020,9(2),121-129","journal-title":"J Herbmed Pharmacol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s13311-016-0470-2","volume":"13","author":"Bustamante A","year":"2016","unstructured":"Bustamante A; Simats A; Vilar-Bergua A; Garc\u00eda-Berrocoso T; Montaner JJN; Blood\/brain biomarkers of inflammation after stroke and their association with outcome: From C-reactive protein to damage-associated molecular patterns. Neurotherapeutics 2016,13(4),671-684","journal-title":"Neurotherapeutics"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2013.09.023","volume":"555","author":"Zhong Z.","year":"2013","unstructured":"Zhong Z.; Wang B.; Dai M.; Sun Y.; Sun Q.; Yang G.; Bian L.; Carvacrol alleviates cerebral edema by modulating AQP4 expression after intracerebral hemorrhage in mice. Neurosci Lett 2013,555,24-29","journal-title":"Neurosci Lett"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/cells7120231","volume":"7","author":"Hong D.K.","year":"2018","unstructured":"Hong D.K.; Choi B.Y.; Kho A.R.; Lee S.H.; Jeong J.H.; Kang B.S.; Kang D.H.; Park K.H.; Suh S.W.; Carvacrol attenuates hippocampal neuronal death after global cerebral ischemia via inhibition of transient receptor potential melastatin 7. Cells 2018,7(12),231","journal-title":"Cells"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5114\/fn.2019.83831","volume":"57","author":"Olczak M.","year":"2019","unstructured":"Olczak M.; Poniatowski \u0141.; Kwiatkowska M.; Samoj\u0142owicz D.; Tarka S.; Wierzba-Bobrowicz T.; Immunolocalization of dynein, dynactin, and kinesin in the cerebral tissue as a\u00a0possible supplemental diagnostic tool for traumatic brain injury in postmortem examination. Folia Neuropathol 2019,57(1),51-62","journal-title":"Folia Neuropathol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5114\/fn.2020.94006","volume":"58","author":"Cao Y.","year":"2020","unstructured":"Cao Y.; Chen Y.; Wang F.; Wang Y.; Long J.; PARP1 might enhance the therapeutic effect of tetrahydroxystilbene glucoside in traumatic brain injury via inhibition of Ras\/JNK signalling pathway. Folia Neuropathol 2020,58(1),45-56","journal-title":"Folia Neuropathol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainresbull.2013.09.011","volume":"99","author":"Xu GZ.","year":"2013","unstructured":"Xu GZ.; Wang MD.; Liu KG.; Bai YA.; Wu W.; Li W.; A meta-analysis of treating acute traumatic brain injury with calcium channel blockers. Brain Res Bull 2013,99,41-47","journal-title":"Brain Res Bull"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/ph6070788","volume":"6","author":"Gurkoff G.","year":"2013","unstructured":"Gurkoff G.; Shahlaie K.; Lyeth B.; Berman R.; Voltage-gated calcium channel antagonists and traumatic brain injury. Pharmaceuticals (Basel) 2013,6(7),788-812","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuint.2015.07.020","volume":"90","author":"Li WT","year":"2015","unstructured":"Li WT; Zhang SY; Zhou YF; Carvacrol attenuates traumatic neuronal injury through store-operated Ca2+ entry-independent regulation of intracellular Ca2+ homeostasis. Neurochem Int 2015,90,107-13","journal-title":"Neurochem Int"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"DeTure MA","year":"2019","unstructured":"DeTure MA; Dickson DW; The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 2019,14(1),1-18","journal-title":"Mol Neurodegener"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1474-4422(13)70257-6","volume":"13","author":"Reiman E.M.","year":"2014","unstructured":"Reiman E.M.; Alzheimer\u2019s disease and other dementias: Advances in 2013. Lancet Neurol 2014,13(1),3-5","journal-title":"Lancet Neurol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e0227618","DOI":"10.1371\/journal.pone.0227618","volume":"15","author":"Kwak D.E.","year":"2020","unstructured":"Kwak D.E.; Ko T.; Koh H.S.; Ji Y.W.; Shin J.; Kim K.; Kim H.Y.; Lee H.K.; Kim Y.; Alterations of aqueous humor A\u03b2 levels in A\u03b2-infused and transgenic mouse models of Alzheimer disease. PLoS One 2020,15(1),e0227618","journal-title":"PLoS One"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1111\/j.1460-9568.2005.04457.x","volume":"22","author":"Wang Q.","year":"2005","unstructured":"Wang Q.; Wu J.; Rowan M.J.; Anwyl R.; \u03b2-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor. Eur J Neurosci 2005,22(11),2827-2832","journal-title":"Eur J Neurosci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"Singh A","year":"2019","unstructured":"Singh A; Kukreti R; Saso L; Kukreti SJM; Oxidative stress: A key modulator in neurodegenerative diseases. 2019,24(8),1583"},{"key":"ref=56","first-page":"433","volume":"23","author":"Rodella L.F.","year":"2008","unstructured":"Rodella L.F.; Ricci F.; Borsani E.; Stacchiotti A.; Foglio E.; Favero G.; Rezzani R.; Mariani C.; Bianchi R.; Aluminium exposure induces Alzheimer\u2019s disease-like histopathological alterations in mouse brain. Histol Histopathol 2008,23(4),433-439","journal-title":"Histol Histopathol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1007\/s11033-019-04907-3","volume":"46","author":"Medhat D","year":"2019","unstructured":"Medhat D; El-Mezayen HA; El-Naggar ME; Evaluation of urinary 8-hydroxy-2-deoxyguanosine level in experimental Alzheimer\u2019s disease: Impact of carvacrol nanoparticles. Mol Biol Rep 2019,46(4),4517-4527","journal-title":"Mol Biol Rep"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/FBP.0b013e3283534301","volume":"23","author":"Azizi Z.","year":"2012","unstructured":"Azizi Z.; Ebrahimi S.; Saadatfar E.; Kamalinejad M.; Majlessi N.; Cognitive-enhancing activity of thymol and carvacrol in two rat models of dementia. Behav Pharmacol 2012,23(3),241-249","journal-title":"Behav Pharmacol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"Poewe W.","year":"2017","unstructured":"Poewe W.; Seppi K.; Tanner C.M.; Halliday G.M.; Brundin P.; Volkmann J.; Schrag A.E.; Lang A.E.; Parkinson disease. Nat Rev Dis Primers 2017,3(1),17013","journal-title":"Nat Rev Dis Primers"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1590\/0004-282x20170193","volume":"76","author":"Haddadi H.","year":"2018","unstructured":"Haddadi H.; Rajaei Z.; Alaei H.; Shahidani S.; Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson\u2019s disease. Arq Neuropsiquiatr 2018,76(2),71-77","journal-title":"Arq Neuropsiquiatr"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12640-019-00088-w","volume":"37","author":"Manouchehrabadi M.","year":"2020","unstructured":"Manouchehrabadi M.; Farhadi M.; Azizi Z.; Torkaman-Boutorabi A.; Carvacrol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro models of Parkinson\u2019s disease. Neurotox Res 2020,37(1),156-170","journal-title":"Neurotox Res"},{"key":"ref=62","first-page":"29","volume":"2","author":"Baluchnejadmojarad T.","year":"2014","unstructured":"Baluchnejadmojarad T.; Hassanshahi J.; Roghani M.; Mansouri M.; Raoufi S.; Protective effect of carvacrol in 6-hydroxydopamine hemi-parkinsonian rat model. Int J Basic Clin Pharmacol 2014,2(2),29-34","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0887-8994(98)00011-3","volume":"19","author":"Kwong KL","year":"1998","unstructured":"Kwong KL; Wong SN; So KT; Epilepsy in children with cerebral palsy. Pediatr Neurol 1998,19(1),31-36","journal-title":"Pediatr Neurol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/epi.13645","volume":"58","author":"Khalil A","year":"2017","unstructured":"Khalil A; Kovac S; Morris G; Walker MC; Carvacrol after status epilepticus (SE) prevents recurrent SE, early seizures, cell death, and cognitive decline. Epilepsia 2017,58(2),263-273","journal-title":"Epilepsia"},{"key":"ref=65","first-page":"11","volume":"4","author":"Baluchnejadmojarad T.","year":"2016","unstructured":"Baluchnejadmojarad T.; Roghani M.; The protective effect of carvacrol on kainic acid-induced model of temporal lobe epilepsy in male rat. Int J Basic Clin Pathophysiol 2016,4(2),11-16","journal-title":"Int J Basic Clin Pathophysiol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1016\/j.bmcl.2014.10.028","volume":"24","author":"Mishra R.K.","year":"2014","unstructured":"Mishra R.K.; Baker M.T.; Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model. Bioorg Med Chem Lett 2014,24(23),5446-5449","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/MN:34:3:249","volume":"34","author":"Zhao H","year":"2006","unstructured":"Zhao H; Sapolsky RM; Steinberg GK; Phosphoinositide-3-kinase\/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobio 2006,34(3),249-269","journal-title":"Mol Neurobio"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2012.04.052","volume":"216","author":"Xiong T","year":"2012","unstructured":"Xiong T; Tang J; Zhao J; Involvement of the Akt\/GSK-3\u03b2\/CRMP-2 pathway in axonal injury after hypoxic\u2013ischemic brain damage in neonatal rat. Neuroscience 2012,216,123-132","journal-title":"Neuroscience"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s11064-015-1519-z","volume":"40","author":"Assentoft M.","year":"2015","unstructured":"Assentoft M.; Larsen B.R.; MacAulay N.; Regulation and function of AQP4 in the central nervous system. Neurochem Res 2015,40(12),2615-2627","journal-title":"Neurochem Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/ijms21051603","volume":"21","author":"Vandebroek A.","year":"2020","unstructured":"Vandebroek A.; Yasui M.; Regulation of AQP4 in the central nervous system. Int J Mol Sci 2020,21(5),1603","journal-title":"Int J Mol Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.4161\/auto.5.7.9728","volume":"5","author":"Puyal J.","year":"2009","unstructured":"Puyal J.; Clarke P.G.; Targeting autophagy to prevent neonatal stroke damage. Autophagy 2009,5(7),1060-1061","journal-title":"Autophagy"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41419-019-1374-y","volume":"10","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Xu N.; Ding Y.; Doycheva D.M.; Zhang Y.; Li Q.; Flores J.; Haghighiabyaneh M.; Tang J.; Zhang J.H.; Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23\/CAMKK2\/AMPK pathway in neonatal hypoxic-ischemic encephalopathy. Cell Death Dis 2019,10(2),97","journal-title":"Cell Death Dis"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"Dixon SJ","year":"2012","unstructured":"Dixon SJ; Lemberg KM; Lamprecht MR; Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 2012,149(5),1060-1072","journal-title":"Cell"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","volume":"1861","author":"Latunde-Dada GO","year":"2017","unstructured":"Latunde-Dada GO; Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta 2017,1861(8),1893-1900","journal-title":"Biochim Biophys Acta"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1479-5876-7-97","volume":"7","author":"Lakhan S.E.","year":"2009","unstructured":"Lakhan S.E.; Kirchgessner A.; Hofer M.; Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. J Transl Med 2009,7(1),97","journal-title":"J Transl Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1021\/acsnano.8b06572","volume":"13","author":"Dong X.","year":"2019","unstructured":"Dong X.; Gao J.; Zhang C.Y.; Hayworth C.; Frank M.; Wang Z.; Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano 2019,13(2),1272-1283","journal-title":"ACS Nano"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/CIA.S233909","volume":"15","author":"Pawluk H.","year":"2020","unstructured":"Pawluk H.; Wo\u017aniak A.; Grze\u015bk G.; Ko\u0142odziejska R.; Kozakiewicz M.; Kopkowska E.; Grzechowiak E.; Kozera G.; The role of selected pro-inflammatory cytokines in pathogenesis of ischemic stroke. Clin Interv Aging 2020,15,469-484","journal-title":"Clin Interv Aging"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.biopha.2016.11.057","volume":"85","author":"Bazmandegan G","year":"2017","unstructured":"Bazmandegan G; Boroushaki MT; Shamsizadeh A; Brown propolis attenuates cerebral ischemia-induced oxidative damage via affecting antioxidant enzyme system in mice. Biomed Pharmacother 2017,85,503-510","journal-title":"Biomed Pharmacother"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/00015458.2018.1455418","volume":"119","author":"Dehnamaki F","year":"2019","unstructured":"Dehnamaki F; Karimi A; Pilevarian AA; Treatment with troxerutin protects against cisplatin-induced kidney injury in mice. Acta Chir Belg 2019,119(1),31-37","journal-title":"Acta Chir Belg"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neuint.2015.07.020","volume":"90","author":"Li WT.","year":"2015","unstructured":"Li WT.; Zhang SY.; Zhou YF.; Zhang BF.; Liang ZQ.; Liu YH.; Wei Y.; Li C.K.; Meng X.J.; Xia M.; Dan Y.; Song J.N.; Carvacrol attenuates traumatic neuronal injury through store-operated Ca(2+) entry-independent regulation of intracellular Ca(2+) homeostasis. Neurochem Int 2015,90,107-113","journal-title":"Neurochem Int"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","volume":"69","author":"Ansari M.A.","year":"2010","unstructured":"Ansari M.A.; Scheff S.W.; Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 2010,69(2),155-167","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2105607","DOI":"10.1155\/2019\/2105607","volume":"2019","author":"Cenini G","year":"2019","unstructured":"Cenini G; Lloret A; Cascella R; Oxidative stress in neurodegenerative diseases: From a mitochondrial point of view. Oxid Med Cell Longev 2019,2019,2105607","journal-title":"Oxid Med Cell Longev"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"T\u00f6nnies E.","year":"2017","unstructured":"T\u00f6nnies E.; Trushina E.; Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis 2017,57(4),1105-1121","journal-title":"J Alzheimers Dis"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/fcp.12280","volume":"31","author":"Zamanian M.","year":"2017","unstructured":"Zamanian M.; Hajizadeh M.R.; Esmaeili Nadimi A.; Shamsizadeh A.; Allahtavakoli M.; Antifatigue effects of troxerutin on exercise endurance capacity, oxidative stress and matrix metalloproteinase-9 levels in trained male rats. Fundam Clin Pharmacol 2017,31(4),447-455","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1139\/cjpp-2016-0653","volume":"95","author":"Zamanian M.","year":"2017","unstructured":"Zamanian M.; Shamsizadeh A.; Esmaeili Nadimi A.; Hajizadeh M.; Allahtavakoli F.; Rahmani M.; Kaeidi A.; Safari Khalegh H.; Allahtavakoli M.; Short-term effects of troxerutin (vitamin P4) on muscle fatigue and gene expression of Bcl-2 and Bax in the hepatic tissue of rats. Can J Physiol Pharmacol 2017,95(6),708-713","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3892\/ol.2012.931","volume":"4","author":"Zitka O.","year":"2012","unstructured":"Zitka O.; Skalickova S.; Gumulec J.; Masarik M.; Adam V.; Hubalek J.; Trnkova L.; Kruseova J.; Eckschlager T.; Kizek R.; Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol Lett 2012,4(6),1247-1253","journal-title":"Oncol Lett"},{"key":"ref=87","first-page":"297","volume":"46","author":"Jellinger K.","year":"1995","unstructured":"Jellinger K.; Linert L.; Kienzl E.; Herlinger E.; Youdim M.B.; Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson\u2019s disease. J Neural Transm Suppl 1995,46,297-314","journal-title":"J Neural Transm Suppl"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1748-1716.1961.tb02115.x","volume":"51","author":"Bertler \u00c5.","year":"1961","unstructured":"Bertler \u00c5.; Effect of reserpine on the storage of catechol amines in brain and other tissues. Acta Physiol Scand 1961,51(1),75-83","journal-title":"Acta Physiol Scand"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbr.2013.06.031","volume":"253","author":"Santos J.R.","year":"2013","unstructured":"Santos J.R.; Cunha J.A.; Dierschnabel A.L.; Camp\u00ealo C.L.; Le\u00e3o A.H.; Silva A.F.; Engelberth R.C.; Iz\u00eddio G.S.; Cavalcante J.S.; Ab\u00edlio V.C.; Ribeiro A.M.; Silva R.H.; Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine. Behav Brain Res 2013,253,68-77","journal-title":"Behav Brain Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"Schober A.","year":"2004","unstructured":"Schober A.; Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res 2004,318(1),215-224","journal-title":"Cell Tissue Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"e75532","DOI":"10.1371\/journal.pone.0075532","volume":"8","author":"Hernandes M.S.","year":"2013","unstructured":"Hernandes M.S.; Santos G.D.; Caf\u00e9-Mendes C.C.; Lima L.S.; Scavone C.; Munhoz C.D.; Britto L.R.; Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration. PLoS One 2013,8(9),e75532","journal-title":"PLoS One"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1097\/01.ASN.0000129115.69395.65","volume":"15","author":"Huang CL","year":"2004","unstructured":"Huang CL; The transient receptor potential superfamily of ion channels. J Am Soc Nephrol 2004,15(7),1690-1699","journal-title":"J Am Soc Nephrol"},{"key":"ref=93","first-page":"11","volume":"4","author":"Baluchnejadmojarad T","year":"2016","unstructured":"Baluchnejadmojarad T; Roghani M; The protective effect of carvacrol on kainic acid-induced model of temporal lobe epilepsy in male rat. J Basic Clin Pathophysiol 2016,4(2),11-16","journal-title":"J Basic Clin Pathophysiol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","volume":"20","author":"L\u00f6scher W","year":"2011","unstructured":"L\u00f6scher W; Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 2011,20(5),359-368","journal-title":"Seizure"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/193219","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/193219\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/193219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T10:40:11Z","timestamp":1639564811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/193219\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":94,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,12,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527320666210506185042","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}